PDS Biotechnology (Germany) Top Insiders

EU6 Stock  EUR 1.67  0.09  5.70%   
PDS Biotechnology employs about 22 people. The company is managed by 20 executives with a total tenure of roughly 65 years, averaging almost 3.0 years of service per executive, having 1.1 employees per reported executive. Examination of PDS Biotechnology's management performance can provide insight into the company performance.
Frank BeduAddo  CEO
President, Chief Executive Officer, Director
Stephen Glover  Chairman
Independent Chairman of the Board
  
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in PDS Biotechnology Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

PDS Biotechnology Management Team Effectiveness

The company has return on total asset (ROA) of (0.2487) % which means that it has lost $0.2487 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.488) %, meaning that it generated substantial loss on money invested by shareholders. PDS Biotechnology's management efficiency ratios could be used to measure how well PDS Biotechnology manages its routine affairs as well as how well it operates its assets and liabilities.

PDS Biotechnology Workforce Comparison

PDS Biotechnology Corp is one of the top stocks in number of employees category among its peers. The total workforce of Biotechnology industry is currently estimated at about 5,169. PDS Biotechnology adds roughly 22.0 in number of employees claiming only tiny portion of stocks in Biotechnology industry.

PDS Biotechnology Corp Benchmark Summation

Operator
The output start index for this execution was zero with a total number of output elements of sixty-one. PDS Biotechnology Corp Price Series Summation is a cross summation of PDS Biotechnology price series and its benchmark/peer.

PDS Biotechnology Notable Stakeholders

A PDS Biotechnology stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as PDS Biotechnology often face trade-offs trying to please all of them. PDS Biotechnology's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting PDS Biotechnology's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Frank BeduAddoPresident, Chief Executive Officer, DirectorProfile
Stephen GloverIndependent Chairman of the BoardProfile
Seth VoorheesChief Financial OfficerProfile
Michael KingInterim Chief Financial OfficerProfile
Otis BrawleyDirectorProfile
Joe DervanVP RDProfile
Deanne RandolphVP RelationsProfile
Gregory ConnChief Scientific OfficerProfile
Spencer JDSr CounselProfile
Nathalie RiebelVP OperationsProfile
Janetta TrochimiukControllerProfile
Lauren WoodChief Medical OfficerProfile
Richard SykesIndependent DirectorProfile
Gregory FreitagIndependent DirectorProfile
Sanjay ZaveriSr DevelProfile
DeLyle BloomquistIndependent DirectorProfile
Kamil AliJacksonIndependent DirectorProfile
Lauren MDChief OfficerProfile
Ilian IlievDirectorProfile
Matthew CPAPrincipal CFOProfile

About PDS Biotechnology Management Performance

The success or failure of an entity such as PDS Biotechnology Corp often depends on how effective the management is. PDS Biotechnology management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of PDS management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the PDS management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. PDS Biotechnology Corporation was founded in 2005 and is based in Florham Park, New Jersey. PDS BIOTECHNOLOGY operates under Biotechnology classification in Germany and is traded on Frankfurt Stock Exchange. It employs 15 people.

PDS Biotechnology Workforce Analysis

Traditionally, organizations such as PDS Biotechnology use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare PDS Biotechnology within its industry.

PDS Biotechnology Manpower Efficiency

Return on PDS Biotechnology Manpower

Revenue Per Employee0.0
Revenue Per Executive0.0
Net Loss Per Employee769K
Net Loss Per Executive845.9K

Complementary Tools for PDS Stock analysis

When running PDS Biotechnology's price analysis, check to measure PDS Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PDS Biotechnology is operating at the current time. Most of PDS Biotechnology's value examination focuses on studying past and present price action to predict the probability of PDS Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PDS Biotechnology's price. Additionally, you may evaluate how the addition of PDS Biotechnology to your portfolios can decrease your overall portfolio volatility.
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Stocks Directory
Find actively traded stocks across global markets
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.